CIPLA LTD vs METROPOLIS HEALTHCARE LTD

A side-by-side comparison of CIPLA LTD (CIPLA) and METROPOLIS HEALTHCARE LTD (METROPOLIS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, CIPLA LTD leads CIPLA vs METROPOLIS on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

29.54
P/E ratio
59.47
3.42
P/B ratio
7.46
0.90%
Dividend yield
0.89%
₹48.02
EPS
₹9.17

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

11.60%
Return on equity
13.80%
15.00%
Return on capital
18.00%
21.00%
EBITDA margin
24.00%
13.71%
Net margin
11.60%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

7.37%
Revenue CAGR (3Y)
12.76%
10.88%
Profit CAGR (3Y)
10.13%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.15L Cr
Market cap
₹11,323 Cr
₹28,163 Cr
Revenue
₹1,646 Cr
₹3,862 Cr
Net profit
₹191 Cr
0.02
Debt / equity
0.15
CIPLA LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
  • ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.34%"]
METROPOLIS HEALTHCARE LTD
  • ["Stock is trading at 7.78 times its book value", "The company has delivered a poor sales growth of 10.5% over past five years.", "Company has a low return on equity of 12.6% over last 3 years."]
CIPLA LTD full analysis METROPOLIS HEALTHCARE LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

CIPLA LTD vs METROPOLIS HEALTHCARE LTD: Share Price, Valuation & Which to Buy | DocStoX